Hoth Therapeutics News

Hoth Therapeutics Is Maintained at Buy by D. Boral Capital

Dow JonesNov 13 18:09 ET

Hoth Therapeutics Analyst Ratings

BenzingaNov 13 17:59 ET

H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 4 06:31 ET

Hoth Therapeutics Analyst Ratings

BenzingaOct 16 06:39 ET

H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsOct 16 06:35 ET

Hoth Therapeutics: Advancements in Alzheimer's and Skin Toxicity Therapies Drive Buy Rating

TipRanksOct 16 06:28 ET

Benchmark Co. Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsOct 11 18:31 ET

Hoth Therapeutics Price Target Maintained With a $3.00/Share by Benchmark

Dow JonesOct 11 12:33 ET

Hoth Therapeutics Analyst Ratings

BenzingaSep 5 15:07 ET

EF Hutton Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target

BenzingaSep 5 15:07 ET

EF Hutton Initiates Hoth Therapeutics(HOTH.US) With Buy Rating, Announces Target Price $5

Moomoo NewsAug 21 13:31 ET

Hoth Therapeutics Price Target Announced at $5.00/Share by EF Hutton

Dow JonesAug 21 09:26 ET

Hoth Therapeutics Analyst Ratings

BenzingaAug 21 09:15 ET

Hoth Therapeutics Analyst Ratings

BenzingaAug 16 06:37 ET

Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)

TipRanksAug 16 06:37 ET

H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 16 06:31 ET

Hoth Therapeutics Analyst Ratings

BenzingaJul 26 07:15 ET

H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsJul 26 06:31 ET

Buy Rating Affirmed for Hoth Therapeutics on Strategic Partnerships and Promising Alzheimer's Treatment Advances

TipRanksJul 26 06:23 ET

Hoth Therapeutics' Expansion and AI Integration Bolster Buy Rating

TipRanksJul 22 06:34 ET